# Maraganore John: insider transactions

SEC CIK 1180432. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-22.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Rapport Therapeutics, Inc.](/companies/rapp.md) | Director | 2 | 2026-10-22 | 2026-10-22 |

## Transactions: 2

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-22 | [Rapport Therapeutics, Inc.](/companies/rapp.md) | Purchase (P) | 1,172 | $26.9173 | $31.5k | [Form 4](/filings/0001193125-26-429071.md) |
| 2026-10-22 | [Rapport Therapeutics, Inc.](/companies/rapp.md) | Purchase (P) | 8,239 | $26.3799 | $217.3k | [Form 4](/filings/0001193125-26-429071.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 01:37 ET. No prices; not investment advice.